Overview

Apheresis Systems Market Introduction

Apheresis Systems Market is envisioned to value over US $ 4 billion by the end of 2027 and record at a CAGR of over 7% during the forecast period of 2020-2027. 

Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for
therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting.

The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for the market growth

The Asia Pacific account significant share in the global market and created potential opportunities for international players due to increasing government support. It is majorly dominated by domestic manufacturers and expected to remain the same throughout the forecast period. Whereas, developed economies like North America & Europe witnessed strong penetration due to the increasing prevalence and stringent regulatory conditions. US, UK, France, Japan, and Germany account a major share in the global market due to high penetration. Latin America and Rest of World regions witnessed fast growth rate during the forecast period due to increasing adoption.

Major market players include 
TERUMO BCT, INC., Fresenius Kabi, B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd, Macopharma, Grifolss, Delcon Medical Devices, and others.

Apheresis Systems Market Segmentation:

By Product Type

• Standalone Apheresis Systems
• Portable Apheresis Systems
• Consumables and Supplies

By End User

• Hospitals
• Outpatient Centres
• Blood Banks

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Rest of the World

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major    market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global Apheresis Systems Market by Product Type, by End User, by Region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Table of Contents

1. Market Introduction
         1.1. Objectives of the Study 
         1.2. Market Definition 
         1.3. Market Scope 
                1.3.1. Years Considered for the Study
                1.3.2. Market Covered
         1.4. Currency 
         1.5. Limitations 
         1.6. Stakeholders 
 2.  Research Methodology 
         2.1. Research Data 
                2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                2.1.2. Primary Data
                           2.1.2.1. Key Data from Primary Sources
         2.2. Market Size Estimation 
         2.3. Market Breakdown and Data Triangulation 
         2.4. Assumptions for the Study  
3. Executive Summary
         3.1. Market Outlook
         3.2. Segment Outlook
         3.3. Competitive Insights
4. Global Apheresis Systems Market Variables, Trends & Scope
         4.1. Market Lineage Outlook
         4.2. Penetration and Growth Prospect Mapping
         4.3. Industry Value Chain Analysis
         4.4. Cost Analysis Breakdown
         4.5. Technology Overview
         4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Apheresis Systems Market Overview
         5.1. Market Dynamics
                 5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Apheresis Systems Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                 5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                 5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Apheresis Systems Market Analysis Tools
         6.1. Industry Analysis - Porter’s
                 6.1.1. Supplier Power
                 6.1.2. Buyer Power
                 6.1.3. Substitution Threat
                 6.1.4. Threat from New Entrants
                 6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
                 6.2.1. Political Landscape
                 6.2.2. Environmental Landscape
                 6.2.3. Social Landscape
                 6.2.4. Technology Landscape
                 6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                 6.3.1. Joint Ventures
                 6.3.2. Mergers and Acquisitions
                 6.3.3. Licensing and Partnership
                 6.3.4. Technology Collaborations
                 6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Apheresis Systems Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
         7.1. Standalone Apheresis Systems
         7.2. Portable Apheresis Systems
         7.3. Consumables and Supplies
8. Global Apheresis Systems Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
         8.1. Hospitals
         8.2. Outpatient Centres
         8.3. Blood Banks
9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         9.1. Introduction
         9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                 9.2.1. U.S.A
                 9.2.2. Canada
                 9.2.3. Mexico
         9.3. Market Size (USD Million) Forecast for North America 2020-2027 
10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                   10.2.1. Brazil
                   10.2.2. Venezuela
                   10.2.3. Argentina
                   10.2.4. Rest of Latin America
         10.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                   11.2.1. Germany
                   11.2.2. U.K
                   11.2.3. France
                   11.2.4. Italy
                   11.2.5. Spain
                   11.2.6. Russia
                   11.2.7. Poland
                   11.2.8. Rest of Europe
         11.3. Market Size (USD Million) Forecast for Europe 2020-2027
12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                   12.2.1. Japan
                   12.2.2. China
                   12.2.3. India
                   12.2.4. Australia and New Zealand
                   12.2.5. ASEAN
                   12.2.6. Rest of Asia Pacific
         12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                   13.2.1. Saudi Arabia
                   13.2.2. UAE
                   13.2.3. South Africa
                   13.2.4. Egypt
         13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
         14.1. TERUMO BCT, INC.
                   14.1.1. Company Overview
                   14.1.2. Product Portfolio
                   14.1.3. SWOT Analysis
                   14.1.4. Financial Overview
                   14.1.5. Strategic Overview
         14.2. Fresenius Kabi
                   14.2.1. Company Overview
                   14.2.2. Product Portfolio
                   14.2.3. SWOT Analysis
                   14.2.4. Financial Overview
                   14.2.5. Strategic Overview
         14.3. B. Braun Melsungen AG,
                   14.3.1. Company Overview
                   14.3.2. Product Portfolio
                   14.3.3. SWOT Analysis
                   14.3.4. Financial Overview
                   14.3.5. Strategic Overview
         14.4. Asahi Kasei Medical Co., Ltd
                   14.4.1. Company Overview
                   14.4.2. Product Portfolio
                   14.4.3. SWOT Analysis
                   14.4.4. Financial Overview
                   14.4.5. Strategic Overview
         14.5 Macopharma
                  14.5.1. Company Overview
                  14.5.2. Product Portfolio
                  14.5.3. SWOT Analysis
                  14.5.4. Financial Overview
                  14.5.5. Strategic Overview
         14.6 Grifolss
                  14.6.1. Company Overview
                  14.6.2. Product Portfolio
                  14.6.3. SWOT Analysis
                  14.6.4. Financial Overview
                  14.6.5. Strategic Overview
         14.7. Delcon Medical Devices
                  14.7.1. Company Overview
                  14.7.2. Product Portfolio
                  14.7.3. SWOT Analysis
                  14.7.4. Financial Overview
                  14.7.5. Strategic Overview
15. FutureWise SME Key Takeaway Points for Client

Tables

Figures